Image

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Evaluating long-term safety of Astegolimab for COPD patients.

Recruiting
40-90 years
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

Study Purpose: This study looks at how safe a medicine called astegolimab is for people with Chronic Obstructive Pulmonary Disease (COPD) over a long time. COPD is a lung disease that makes it hard to breathe. This study is for people who have already been in a similar study for 52 weeks.

Who Can Join: To join, you must have finished the 52-week treatment in one of the earlier studies named GB43311 or GB44332. You cannot join if you stopped the earlier study early, had any major problems following study rules, or have any new serious heart or lung illnesses.

  • The study checks safety after a 52-week prior treatment.
  • Participants must have completed specific earlier studies.
  • New serious health issues may disqualify participation.

This study helps understand how safe astegolimab is for people with COPD over a long time. It’s important to follow all the study rules and report any new health issues to the doctors. If you think you might qualify, talk to your doctor about joining.

Print
Study details
    Chronic Obstructive Pulmonary Disease

NCT05878769

Hoffmann-La Roche

22 February 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.